- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01946217
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
PRIMARY OBJECTIVES:
I. To identify participant-level factors affecting recruitment of potentially eligible participants in AIDS Malignancy Clinical Trials Consortium (AMC) studies at core and affiliated sites.
SECONDARY OBJECTIVES:
I. To describe the socio-demographic characteristics for participation and non-participation in AMC clinical trials among all approached volunteers across AMC sites.
II. To characterize socio-demographic characteristics with motivation and decision making among those who consented to participate in an AMC trial.
III. To identify the perceived barriers associated with clinical trial participation among those who did not consent to participate in an AMC clinical trial.
IV. To better understand how potential study volunteers learn about AMC clinical trials and by what means are they referred to a particular study.
OUTLINE:
Participants complete the Improving Participation in AMC Clinical Trials (IMPACTS) survey comprising questions about socio-demographic information and clinical trial participation.
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
California
-
Los Angeles, California, Estados Unidos, 90024
- UCLA Clinical AIDS Research and Education (CARE) Center
-
-
Illinois
-
Chicago, Illinois, Estados Unidos, 60612
- Stroger Hospital of Cook County
-
-
Louisiana
-
New Orleans, Louisiana, Estados Unidos, 70112
- Interim LSU Public Hospital
-
New Orleans, Louisiana, Estados Unidos, 70119
- HIV Out-patient Clinic
-
New Orleans, Louisiana, Estados Unidos, 70119
- NO AIDS Clinic
-
-
New York
-
Bronx, New York, Estados Unidos, 10467
- Montefiore Medical Center
-
Bronx, New York, Estados Unidos, 10461
- Albert Einstein Cancer Center at Albert Einstein College of Medicine
-
Bronx, New York, Estados Unidos, 10461
- Montefiore-Einstein Cancer Center
-
New York, New York, Estados Unidos, 10065
- Memorial Sloan-Kettering Cancer Center
-
New York, New York, Estados Unidos, 10010
- Laser Surgery Care
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Estados Unidos, 15213
- University of Pittsburgh Medical Center
-
-
Washington
-
Seattle, Washington, Estados Unidos, 98109
- Seattle Cancer Care Alliance
-
Seattle, Washington, Estados Unidos, 98101
- Virginia Mason Medical Center
-
Seattle, Washington, Estados Unidos, 98104
- Harborview Madison Clinic
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- HIV-infected participants
- Cancer or anal dysplasia diagnosis
- Offered informed consent on an AMC interventional clinical trial
- Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
- Inability to provide informed consent
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: Grupo
- Perspectivas temporales: Futuro
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
---|---|
Observational (questionnaire administration)
Participants complete the IMPACTS survey comprising questions about socio-demographic information and clinical trial participation.
|
Estudios complementarios
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Participant level factors affecting recruitment of potentially eligible participants in AMC intervention studies
Periodo de tiempo: Up to 2 weeks
|
The proportion of individuals who are screened and agree to enroll in a clinical trial will be estimated with the binomial proportion and its 95% confidence interval.
|
Up to 2 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Socio-demographic characteristics for participation and non-participation in AMC clinical trials among all approached volunteers across AMC sites
Periodo de tiempo: Up to 2 weeks
|
Chi-square tests will be used to compare the characteristics of those who enrolled in a clinical trial with those who did not with respect to sociodemographic characteristics, sexual orientation, and disease-type and design type.
|
Up to 2 weeks
|
Socio-demographic characteristics with motivation and decision making among those who consented to participate in an AMC trial
Periodo de tiempo: Up to 2 weeks
|
Chi-square tests will be used to compare the characteristics of those who enrolled in a clinical trial with those who did not with respect to sociodemographic characteristics, sexual orientation, and disease-type and design type.
|
Up to 2 weeks
|
Perceived barriers associated with clinical trial participation among those who did not consent to participate in an AMC clinical trial
Periodo de tiempo: Up to 2 weeks
|
For each study participant who did not enroll in a trial, the number of barriers in each category (views and attitudes, views of other people around them, financial burden and travel) will be computed.
Summary statistics (mean, standard deviation [SD], median and interquartile range) will be used to estimate number of barriers in each category.
Analyses of variance will be used to assess the associations of sociodemographic characteristics, sexual orientation, disease-type and design-type with the number of barriers in each category.
|
Up to 2 weeks
|
Means by which volunteers are referred to a particular study
Periodo de tiempo: Up to 2 weeks
|
For study participants who enrolled in a clinical trial, the binomial proportion will be used to estimate the proportion who answered affirmatively to each of the six statements related to decision-making about clinical trials, and the individual reasons for participating in clinical trials.
For each study participant who enrolled in a trial, the number of reasons cited for participation will be computed.
Summary statistics mean, SD, median and interquartile range) will be used to estimate number of reasons cited for enrollment.
|
Up to 2 weeks
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- AMC-S006 (Otro identificador: CTEP)
- U01CA121947 (Subvención/contrato del NIH de EE. UU.)
- NCI-2013-01152 (Identificador de registro: CTRP (Clinical Trial Reporting Program))
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Infección por VIH
-
Icahn School of Medicine at Mount SinaiIRRASReclutamientoHemorragia Intraventricular (HIV)Estados Unidos
-
Yale UniversityTerminadoPrecocidad | Recién nacidos de muy bajo peso al nacer | Hemorragia Intraventricular (HIV) | Sangrado en el cerebroEstados Unidos
-
China Medical University HospitalDesconocidoDisplasia broncopulmonar | Bebés extremadamente prematuros | TLP grave que las terapias convencionales han fallado | Sin anomalías congénitas graves | no Hiv Severa Ni FPV QuísticaTaiwán
Ensayos clínicos sobre administración del cuestionario
-
Washington University School of MedicineTerminadoFilariasis linfatica | Oncocercosis | Infecciones por helmintos transmitidos por el suelo (STH)Liberia